TC
FOMX

TFS Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

TFS Capital’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,510
Closed -$107K – 969
2016
Q3 		$107K Sell
11,510
-23,420
-67% -$196K 0.03% 636
2016
Q2 		$222K Buy
+34,930
New +$232K 0.04% 692
2015
Q3 		– Sell
-43,876
Closed -$450K – 1119
2015
Q2 		$450K Buy
+43,876
New +$485K 0.04% 574

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

TFS Capital's FOMX Position: Q4 2016 in Review

TFS Capital sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2016, closing a stake of 11,510 shares — an estimated $107K sold.

TFS Capital first reported a position in FOMX in Q2 2015 and held it in 3 quarters. The position peaked at $450K in Q2 2015. 64 funds tracked by Wall St. Rank hold FOMX as of Q4 2016.

  • TFS Capital reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • TFS Capital sold 11,510 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2016, an estimated $107K.
  • TFS Capital first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 3 quarters.
  • TFS Capital's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $450K in Q2 2015.
  • 64 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2016.

Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.